Table 4.
Results of infectious screening assays (nasopharynx)
| Infectious agent | Assay | Pre-COVID Donors | Pre-COVID Recipients | Post-COVID Donors | Post-COVID Recipients | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seropositive rate | Seronegative rate | n | Seropositive rate | Seronegative rate | n | Seropositive rate | Seronegative rate | n | Seropositive rate | Seronegative rate | n | ||
| Nasal | |||||||||||||
| MRSA | 0% | 100% | 28 | 0% | 100% | 17 | 0% | 100% | 27 | 0% | 100% | 1 | |
| SARS-CoV-2 | COVID-19 RT-PCR | N/A | N/A | N/A | N/A | N/A | N/A | 0% | 100% | 27 | 0% | 100% | 1 |